Synfacts 2019; 15(08): 0833
DOI: 10.1055/s-0039-1690443
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of (+)-Longirabdiol, (–)-Longirabdolactone, and (–)-Effusin

Erick M. Carreira
Niels Sievertsen
Zhang J, Li Z, Zhuo J, Cui Y, Han T, Li C. * National Institute of Biological Sciences, Beijing, Tsinghua University, Beijing, Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, P. R. of China
Tandem Decarboxylative Cyclization/Alkenylation Strategy for Total Syntheses of (+)-Longirabdiol, (–)-Longirabdolactone, and (–)-Effusin.

J. Am. Chem. Soc. 2019;
141: 8372-8380
Further Information

Publication History

Publication Date:
18 July 2019 (online)



Owing to their well-established biological effects and structural complexity, ent-kaurane diterpenoid natural products continue to attract interest from the synthetic community. Li and co-workers present enantioselective total syntheses of three spirolactone ent-kauranoids by relying on a sequence involving an elegant tandem decarboxylative cyclization alkenylation. Two additional free radical-based cyclization events allowed the team to access (+)-longirabdiol. Closely related natural products (–)-longirabdolactone and (–)-effusin were synthesized by implementation of few additional transformations.



The authors initiated their synthetic route by preparation of enantioenriched acid C followed by its subsequent transformation into the redox-active ester D. Tandem radical cyclization/alkenylation led to the formation of lactone F with good diastereoselectivity. Following functional group interconversions, intermolecular decarboxylative Giese reaction and intramolecular lactonization gave rise to spiro-compound I. This intermediate was transformed into advanced intermediate J, thereby setting the stage for the last radical cyclization, allylic oxidation, and desilylation to afford (+)-longirabdiol.